PURPOSE OF REVIEW: The availability of organs for transplant fails to meet the demand and this shortage is growing worse every year. As the cost of not getting a suitable donor organ can mean death for patients, new tools and approaches that allows us to make advances in transplantation faster and provide a different vantage point are required. To address this need, we introduce the concept of using the zebrafish (Danio rerio) as a new model system in organ transplantation. The zebrafish community offers decades of research experience in disease modeling and a rich toolbox of approaches for interrogating complex pathological states. We provide examples of how already existing zebrafish assays/tools from cancer, regenerative medicine, immunology, and others, could be leveraged to fuel new discoveries in pursuit of solving the organ shortage. RECENT FINDINGS: Important innovations have enabled several types of transplants to be successfully performed in zebrafish, including stem cells, tumors, parenchymal cells, and even a partial heart transplant. These innovations have been performed against a backdrop of an expansive and impressive list of tools designed to uncover the biology of complex systems that include a wide array of fluorescent transgenic fish that label specific cell types and mutant lines that are transparent, immune-deficient. Allogeneic transplants can also be accomplished using immune suppressed and syngeneic fish. Each of these innovations within the zebrafish community would provide several helpful tools that could be applied to transplant research. SUMMARY: We highlight some examples of existing tools and assays developed in the zebrafish community that could be leveraged to overcome barriers in organ transplantation, including ischemia-reperfusion, short preservation durations, regeneration of marginal grafts, and acute and chronic rejection.
PURPOSE OF REVIEW: The availability of organs for transplant fails to meet the demand and this shortage is growing worse every year. As the cost of not getting a suitable donor organ can mean death for patients, new tools and approaches that allows us to make advances in transplantation faster and provide a different vantage point are required. To address this need, we introduce the concept of using the zebrafish (Danio rerio) as a new model system in organ transplantation. The zebrafish community offers decades of research experience in disease modeling and a rich toolbox of approaches for interrogating complex pathological states. We provide examples of how already existing zebrafish assays/tools from cancer, regenerative medicine, immunology, and others, could be leveraged to fuel new discoveries in pursuit of solving the organ shortage. RECENT FINDINGS: Important innovations have enabled several types of transplants to be successfully performed in zebrafish, including stem cells, tumors, parenchymal cells, and even a partial heart transplant. These innovations have been performed against a backdrop of an expansive and impressive list of tools designed to uncover the biology of complex systems that include a wide array of fluorescent transgenic fish that label specific cell types and mutant lines that are transparent, immune-deficient. Allogeneic transplants can also be accomplished using immune suppressed and syngeneic fish. Each of these innovations within the zebrafish community would provide several helpful tools that could be applied to transplant research. SUMMARY: We highlight some examples of existing tools and assays developed in the zebrafish community that could be leveraged to overcome barriers in organ transplantation, including ischemia-reperfusion, short preservation durations, regeneration of marginal grafts, and acute and chronic rejection.
Authors: J Strnadel; H Wang; C Carromeu; A Miyanohara; K Fujimura; E Blahovcova; V Nosal; H Skovierova; R Klemke; E Halasova Journal: J Mol Neurosci Date: 2018-07-12 Impact factor: 3.444
Authors: J Ziolkowski; L Paczek; M Niewczas; G Senatorski; U Oldakowska-Jedynak; J Wyzgal; B Foroncewicz; K Mucha; J Zegarska; P Nyckowski; K Zieniewicz; W Patkowski; M Krawczyk; B Ziarkiewicz-Wroblewska; B Gornicka Journal: Transplant Proc Date: 2003-09 Impact factor: 1.066
Authors: Chuan Yan; Dalton C Brunson; Qin Tang; Daniel Do; Nicolae A Iftimia; John C Moore; Madeline N Hayes; Alessandra M Welker; Elaine G Garcia; Taronish D Dubash; Xin Hong; Benjamin J Drapkin; David T Myers; Sarah Phat; Angela Volorio; Dieuwke L Marvin; Matteo Ligorio; Lyle Dershowitz; Karin M McCarthy; Murat N Karabacak; Jonathan A Fletcher; Dennis C Sgroi; John A Iafrate; Shyamala Maheswaran; Nick J Dyson; Daniel A Haber; John F Rawls; David M Langenau Journal: Cell Date: 2019-04-25 Impact factor: 41.582
Authors: Colin D Paul; Alexus Devine; Kevin Bishop; Qing Xu; William J Wulftange; Hannah Burr; Kathryn M Daly; Chaunte Lewis; Daniel S Green; Jack R Staunton; Swati Choksi; Zheng-Gang Liu; Raman Sood; Kandice Tanner Journal: Sci Rep Date: 2019-02-11 Impact factor: 4.379
Authors: Caroline N Jones; Felix Ellett; Anne L Robertson; Kevin M Forrest; Kevin Judice; James M Balkovec; Martin Springer; James F Markmann; Jatin M Vyas; H Shaw Warren; Daniel Irimia Journal: Front Immunol Date: 2019-04-09 Impact factor: 7.561